We are delighted to announce that ICON Cancer Foundation will also be joining the CT:IQ Steering Committee.
Speaking on behalf of the Foundation, Fiona Jonker, CEO says that “Icon Cancer Foundation strive to collaborate with other clinical trials sites, public and private, to improve the efficiency and quality of clinical trials opportunities in Australia. We see the launch of CT:IQ as the ideal vehicle for us to take this collaboration, and the impact and quality of clinical trials in Australia, to the next level”.
